{
    "name": "prucalopride",
    "comment": "Rx",
    "other_names": [
        "Motegrity"
    ],
    "classes": [
        "Prokinetic Agents"
    ],
    "source": "https://reference.medscape.com/drug/motegrity-prucalopride-1000289",
    "pregnancy": {
        "common": [
            "Available data from case reports with use in pregnant women are insufficient to identify any drug-associated risks of miscarriage, major birth defects, or adverse maternal or fetal outcomes",
            "A pregnancy exposure registry monitors pregnancy outcomes in women exposed to drug during pregnancy; healthcare providers are encouraged to register patients by contacting MotherToBaby Pregnancy Studies conducted by the Organization of Teratology Information Specialists (OTIS) at 1-877-311-8972 or visiting "
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "In animal reproduction studies, no adverse developmental effects were observed with prucalopride during organogenesis in pregnant rats and rabbits at doses up to ~390x and 780x, respectively, the recommended human dose of 2 mg/day"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Prucalopride is present in breast milk",
            "No data are available of effects on breastfed children or milk production",
            "Consider developmental and health benefits of breastfeeding along with the motherâ€™s clinical need and any potential adverse effects on the breastfed child from prucalopride or from the underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity",
                "Intestinal perforation or obstruction due to structural or functional disorder of gut wall, obstructive ileus, severe inflammatory conditions of the intestinal tract (eg, Crohn disease, ulcerative colitis, toxic megacolon/megarectum)"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": [
                {
                    "type": "Suicidal ideation and behavior",
                    "description": [
                        "In clinical trials, suicides, suicide attempts, and suicidal ideation reported",
                        "A causal association between treatment and an increased risk of suicidal ideation and behavior not established",
                        "Monitor for persistent worsening of depression or the emergence of suicidal thoughts and behaviors",
                        "Instruct patients to discontinue immediately and contact their healthcare provider if they experience any of these symptoms"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Abnormal GI sounds",
            "percent": null
        },
        {
            "name": "Decreased appetite",
            "percent": null
        },
        {
            "name": "Migraine",
            "percent": null
        },
        {
            "name": "Pollakiuria",
            "percent": null
        }
    ]
}